glp 1 based therapeutics summit 2nd GLP-1-Based 2025 [04/29/25] Incretin-based therapies in MASLD/MASH: from

Enhanced repair of connective tissues

These key factors can slow progress: metabolismhow fast your body burns calories at rest whether you dose as directed or skip doses lack of consistent lifestyle changes like diet and exercise stopping because of side effects age having a lower starting weight, BMI, or waist circumference The Bottom Line Both liraglutide and semaglutide help control blood sugar, support weight loss, and lower cardiovascular risk

Muscle carnitine allows the one-way process of shuttling fatty acids into the furnace

Real-world data from electronic health records tells a similar story, though the gap narrows somewhat in patients who also have type 2 diabetes

Moon MS, McDevitt EI, Zhu J, Stanley B, Krzeminski J, Amin S, Aliaga C, Miller TG, Isom HC

mutating all cysteines to serine abolishes this effect